BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20616508)

  • 1. Medical therapy of Cushing's disease: where are we now?
    Alexandraki KI; Grossman AB
    Front Horm Res; 2010; 38():165-173. PubMed ID: 20616508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-targeted medical therapy of Cushing's disease.
    Alexandraki KI; Grossman AB
    Expert Opin Investig Drugs; 2008 May; 17(5):669-77. PubMed ID: 18447593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA; Hofland LJ; de Herder WW
    Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological management of Cushing's syndrome: an update.
    Dang CN; Trainer P
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1339-48. PubMed ID: 18209872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of Cushing's disease: what is the future?
    Fleseriu M; Petersenn S
    Pituitary; 2012 Sep; 15(3):330-41. PubMed ID: 22674211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How best to monitor the specific side effects of medical treatments of Cushing's disease.
    Castinetti F
    Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101718. PubMed ID: 36435719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.
    Feelders RA; de Bruin C; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; van Heerebeek R; de Jong FH; van der Lely AJ; de Herder WW; Hofland LJ; Lamberts SW
    N Engl J Med; 2010 May; 362(19):1846-8. PubMed ID: 20463350
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New prospects for drug treatment in Cushing disease.
    Barahona Constanzo MJ; del Pozo Picó C
    Endocrinol Nutr; 2012 Dec; 59(10):599-605. PubMed ID: 23036936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in medical therapies for Cushing's syndrome.
    Tritos NA; Biller BM
    Discov Med; 2012 Feb; 13(69):171-9. PubMed ID: 22369976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Management of Cushing Disease.
    Tritos NA; Biller BMK
    Neurosurg Clin N Am; 2019 Oct; 30(4):499-508. PubMed ID: 31471057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
    Braun LT; Reincke M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of medical treatment in Cushing's disease: a systematic review.
    Gadelha MR; Vieira Neto L
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):1-12. PubMed ID: 24118077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to the pharmacological management of Cushing's disease.
    Molitch ME
    Mol Cell Endocrinol; 2015 Jun; 408():185-9. PubMed ID: 25450859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of Cushing's disease: somatostatin analogues and pasireotide.
    Pedroncelli AM
    Neuroendocrinology; 2010; 92 Suppl 1():120-4. PubMed ID: 20829632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in the medical therapy of Cushing's disease.
    Nieman LK
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):330-4. PubMed ID: 23807605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the Medical Treatment of Cushing Disease.
    Tritos NA; Biller BMK
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):401-412. PubMed ID: 32741479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of Cushing's disease.
    Feelders RA; Hofland LJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):425-38. PubMed ID: 23345100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.